92814-42-1 Usage
General Description
(R)-6-amino-1,4-thiazepan-5-one is a chemical compound with the molecular formula C5H10N2OS. It is a heterocyclic organic compound that contains a thiazepane ring with an amino group at the 6th carbon and a carbonyl group at the 5th carbon. (R)-6-amino-1,4-thiazepan-5-one has potential pharmaceutical applications, particularly in the development of novel drugs for neurological and psychiatric disorders. It is also being researched for its potential use in treating mood disorders and anxiety. Additionally, (R)-6-amino-1,4-thiazepan-5-one has been investigated for its anti-inflammatory and immunomodulatory properties, making it a potentially important compound for the development of new therapies for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 92814-42-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,8,1 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 92814-42:
(7*9)+(6*2)+(5*8)+(4*1)+(3*4)+(2*4)+(1*2)=141
141 % 10 = 1
So 92814-42-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H10N2OS/c6-4-3-9-2-1-7-5(4)8/h4H,1-3,6H2,(H,7,8)
92814-42-1Relevant articles and documents
Synthesis and evaluation of thiazepines as interleukin-1β converting enzyme (ICE) inhibitors
Ellis, Christopher D.,Oppong, Kofi A.,Laufersweiler, Michael C.,O'Neil, Steven V.,Soper, David L.,Wang, Yili,Wos, John A.,Fancher, Amy N.,Lu, Wei,Suchanek, Maureen K.,Wang, Richard L.,De, Biswanath,Demuth Jr., Thomas P.
, p. 4728 - 4732 (2007/10/03)
A series of monocyclic thiazepine inhibitors of interleukin-1β converting enzyme (ICE) were synthesized in eight steps from commercially available intermediates. In vitro biological evaluation showed the thiazepines to be moderately potent ICE inhibitors,
DERIVATIVES OF AZEPINE AND THIAZERAN AS INTERLEUKIN CONVERTING ENZYME INHIBITORS
-
Page 87, (2010/02/04)
The present invention relates to interleukin - Iβ converting enzyme inhibitors of formula I: wherein each X is independently selected from: i) -C(W)2-; ii) -C(O)-; iii) -NR2-; iv) -S-; v) -S(O)-; vi) -S(O)2-; vii) two units, one from each adjacent X unit,